KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,983,125 | +333.4% | 2,474,561 | +251.3% | 5.17% | +269.9% |
| Q2 2023 | $9,918,783 | +204.4% | 704,459 | +231.1% | 1.40% | +1.3% |
| Q3 2020 | $3,259,000 | -36.1% | 212,746 | +6.3% | 1.38% | -39.3% |
| Q2 2020 | $5,099,000 | +64.6% | 200,125 | 0.0% | 2.27% | +21.0% |
| Q1 2020 | $3,098,000 | +69.5% | 200,125 | +21.1% | 1.88% | +69.6% |
| Q4 2019 | $1,828,000 | – | 165,318 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |